Federal Circuit Backtracks on Negative Claim Limitations in Fingolimod Patent
Novartis Pharms. Corp. v. Accord Healthcare Inc., No. 2021-1070 (Fed. Cir. June 21, 2022).
Filing Provisional Patent Applications for Fun and Profit!
A Brief Guide to Provisional Patent Applications for Scientists, Engineers, and Executives
Many people hav...
Recent Court Case Highlights Negative Claim Limitations and Best Practices in Drafting Patent Applications
A recent decision by the Federal Circuit (Novartis Pharms. Corp. v. HEC Pharm Co., Ltd., No. 2021-1070 (Fed...
What did They do Differently? Functional Claim Language Overcomes Obviousness finding at PTAB
A rejection based on obviousness can be a difficult rejection for patent applicants to overcome. In patent ...
Patent Ownership in the United States - Best Practices to Preserve Your Rights
The issue of who actually owns a patent or pending patent application is obviously very important. This blo...
“Assignor Estoppel” May Have a Big Impact on Your Patent Assignments
This case pertains to a legal doctrine called “assignor estoppel,” which may have important implications ge...